Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA

Abstract

CRISPR/Cas9 is a programmable genome editing tool widely used for biological applications and engineered Cas9s have increased discrimination against off-target cleavage compared with wild-type Streptococcus pyogenes (SpCas9) in vivo. To understand the basis for improved discrimination against off-target DNA containing important mismatches at the distal end of the guide RNA, we performed kinetic analyses on the high-fidelity (Cas9-HF1) and hyper-accurate (HypaCas9) engineered Cas9 variants. We show that DNA cleavage is impaired by more than 100- fold for the high-fidelity variants. The high-fidelity variants improve discrimination by slowing the observed rate of cleavage without increasing the rate of DNA rewinding and release. The kinetic partitioning favors release rather than cleavage of a bound off-target substrate only because the cleavage rate is so low. Further improvement in discrimination may require engineering increased rates of dissociation of off-target DNA.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 17, 2020
Source ID
10.1038/s41467-020-17411-1

Entities

People

  • David W Taylor
  • Helen-hong Yu
  • Kenneth A. Johnson
  • Kyungseok Jung
  • Mu-Sen Liu
  • Shanzhong Gong

Organizations

  • Army Research Office
  • Cancer Prevention and Research Institute of Texas
  • Robert A. Welch Foundation
  • Robert J Kleberg Jr and Helen C Kleberg Foundation

Tags

Fields of Study

  • Biology

Readers

  • Cellular and Molecular Pathways of Apoptosis.
  • Molecular and genetic basis of cancer.
  • Oncology

Technology Areas

  • Biotechnology